Quality with a Purpose

-

 


All ISO standards are reviewed and revised regularly to make sure they remain relevant to the marketplace. ISO 13485:2016 responds to the latest QMS practices, reflecting the evolution in medical device technology and changes in regulatory requirements and expectations. Transasia is the first Indian IVD Company to receive the ICMED 13485 quality certificate in 2018 for indigenously manufactured medical devices.

 ISO 13485, Medical devices – Quality management systems – Requirements for regulatory purposes, is an internationally agreed standard that sets out the requirements for a quality management system specific to the medical devices industry. Designed to be used by organizations throughout the lifecycle of a medical device, from initial conception to production and post-production, it includes final decommission and disposal. It also covers aspects such as storage, distribution, installation and servicing, and the provision of associated services.

Ensuring process adherence and quality of products

ISO 13485 helps an organization design a quality management system that establishes and maintains the effectiveness of its processes. It reflects a strong commitment to continual improvement and gives customers confidence in its ability to bring safe and effective products to market.


 The PDCA cycle to ensure continual improvement of QMS

This quality management system also enables an organization to consistently provide safe and effective medical devices and fulfill customer and regulatory requirements. It is also flexible enough to meet the individual needs of different types of medical devices organizations.

Benefits

Safety and performance of medical devices are paramount in this highly regulated industry; this is why quality management systems are a regulatory or legal requirement in many countries. ISO 13485 can help organizations involved in any part of a medical device’s life cycle:

  • Demonstrate compliance with regulatory and legal requirements
  • Ensure the establishment of QMS practices that consistently yield safe and effective medical device
  • Manage risk effectively
  • Improve processes and efficiencies as necessary
  • Gain a competitive advantage

 Key improvements

The new version of ISO 13485 places greater emphasis on risk management and risk-based decision making for processes outside the realm of product realization. The focus is on risks associated with the safety and performance of medical devices and compliance with regulatory requirements. In addition, the standard asks organizations to be more stringent when it comes to outsourcing processes by putting into place controls, such as written agreements, for assessing their suppliers – again based on risk.

  • ISO 13485 also reflects the increased regulatory requirements for organizations across the medical devices supply chain, namely:
  • A greater emphasis on appropriate infrastructure, particularly for the production of sterile medical devices, and additional requirements for the validation of sterile barrier properties
  • Increased alignment with regulatory requirements and, in particular, regulatory documentation
  • More focus on post-market activities, including complaint handling and regulatory reporting
  • Broadening of the standard’s application to encompass organizations that interact with the medical devices manufacturer, including those involved in:

o    Design and development or repair and maintenance of medical devices

o    Supply of raw materials, components or subassemblies

o    Performance of services such as contract manufacture, sterilization, logistics or calibration of measurement equipment

o    Import or distribution of medical devices

  •  Additional requirements in the design and development of medical devices, taking into consideration their usability, the use of standards, and a more robust planning for the verification, validation, transfer and records maintenance of the design and   development activities
  • Harmonization of validation requirements for different software applications, such as QMS software, process control software, software for monitoring and measurement

 In conclusion

By following the PDCA cycle, an organization can focus the processes and objectives of the QMS toward overall improvement, leading to increased efficiency and cost savings that can be put toward further improvement. And that is a win-win for both the organization, and its customers.

 

 

 

 


Comments

Post a Comment

Popular posts from this blog

HbA1c: An Important Biomarker in diagnosis and prognosis of diabetes patients

-
Image
  One of the main purposes of laboratory tests is to aid medical reasoning after obtaining the clinical history and performing the physical examination by the laboratory team. To this end, all test execution phases, especially the pre-analytical phase, must be conducted following the technical rigor necessary to ensure patient safety and accurate results, so that the conduction of the patient's prognosis is more assertive. The measurement of HbA1c, when measured in whole blood, by immunoturbidimetric assay, in biochemical equipment from the XL family, such as the XL 200 equipment, plays an important role in the diagnosis of Diabetes. Diabetes is a global endemic with rapidly increasing prevalence in both developing and developed countries. The American Diabetes Association has recommended glycated hemoglobin (HbA1c) as a possible substitute to fasting blood glucose for diagnosis of diabetes. HbA1c is an important indicator of long-term glycemic control with the ability to refle
Read more

Overcome electrolytic analysis challenges with maintenance-free biosensor technology

-
Image
  Find out how to increase the accuracy and reduce the processing time of your routine electrolyte Electrolyte analyzers are routinely used in medical diagnostics to examine physiological conditions within the body. Hospitals and clinical laboratories, as well as treatment sites, rely on electrolyte analyzers to measure the concentration of different ions in the blood, providing important information about the body's electrolyte balance that can be used to detect metabolic imbalances, assess kidney and heart disease and contribute to the early detection of human diseases. However, despite their widespread use, electrolyte analyzers operating with traditional electrode technology are subject to a multitude of challenges, with the need for periodic replacement of electrodes, in particular. In this interview, we speak with Sourav Saha, Product Manager – Critical Care, to learn more about the issues facing clinical labs performing electrolyte analysis and how Erba EC 90, state-of-the
Read more

Amorphous urates: What they are, diagnosis and treatment

-
Image
  Amorphous urates are a type of crystal that varies in colour from yellow to black, identified in the urine test. This can arise due to the cooling of the sample during packaging for transport or due to the acidic pH of the urine, with the values ​​being observed equal to or less than 5.5. Examination of abnormal urine elements and sediment (EAS) can be performed manually or automatically. Automated urinalysis devices available on the market are accurate, reproducible, faster and much less labor intensive (walk-away instruments) than standard manual microscopy. It can be run directly at patient-side without any further sample manipulation (e.g. refrigeration, centrifugation etc.). It has the potential to markedly reduce human factor from interpretation by consistently applying the same algorithm to the analysis of every sample. The Erba Laura XL is an automated device that performs three phases that make up the EAS, from the physical and chemical part to the sedimentoscopy/microscopy,
Read more